Skip to main content

Keros Therapeutics, Inc.

KROS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001664710

In the last 90 days, Keros Therapeutics, Inc. insiders filed 2 open-market purchases and 4 sales; 132 institutions reported holding it in 13F filings for Q2 2026, worth $198.6M in total; no superinvestor holds it.

Q1 2023 vs. Q4 2022

How the institutions holding Keros Therapeutics, Inc. changed between Q4 2022 and Q1 2023.

All holders in Q1 2023All holders in Q4 2022

13F holders of KROS: Q4 2022 compared with Q1 2023
MeasureQ4 2022Q1 2023Change
Holders126129+3
Shares19.7M22.0M+2.26M (+11.4%)
Value$948.2M$937.0M−$11.2M (−1.2%)

New holders (20)

Institutions that held Keros Therapeutics, Inc. at the end of Q1 2023 but not at the end of Q4 2022.

Institutions new to KROS in Q1 2023
InstitutionSharesValue% of portfolio
Paradigm Biocapital Advisors LP930,752$39.7M3.77%
Yiheng Capital Management, L.P.554,151$23.7M1.84%
Eventide Asset Management, LLC300,000$12.8M0.24%
American Century Companies Inc113,143$4.82M0.00%
Sofinnova Investments, Inc.77,100$3.29M0.22%
UBS Oconnor LLC45,484$1.94M0.05%
D. E. Shaw & Co., Inc.31,032$1.33M0.00%
LMR Partners LLP23,671$1.01M0.02%
Jane Street Group, LLC19,042$813.1K0.00%
Tudor Investment Corp Et Al17,666$754.0K0.01%
Algert Global LLC16,595$708.6K0.03%
Ergoteles LLC16,049$685.3K0.03%
Profund Advisors LLC11,844$505.7K0.03%
Mirae Asset Global Investments Co., Ltd.11,539$492.7K0.00%
Janus Henderson Group PLC9,829$419.8K0.00%
AQR Capital Management LLC7,591$324.1K0.00%
Schroder Investment Management Group7,066$297.7K0.00%
Walleye Trading LLC4,962$211.9K0.01%
State of Wyoming575$24.6K0.01%
TCI Wealth Advisors, Inc.73$3.12K0.00%

Sold out (17)

Institutions that held Keros Therapeutics, Inc. at the end of Q4 2022 and filed for Q1 2023 without it.